Replies to post #401314 on NorthWest Biotherapeutics Inc (NWBO)

[anders2211]

I mean ofcourse the build out at the Sawston facility under contract with Advent BioServices.

March 16, 2021 – Northwest Biotherapeutics (OTCQB: NWBO) (“NW Bio”), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced that development of the initial production capacity of the Company’s Sawston, UK advanced manufacturing facility has been completed and the facility is now in the final stages of preparation for an application for certification by the UK Medicines and Health Products Regulatory Authority (“MHRA”).


All of the development activities for the Sawston facility have been carried out under contract with Advent BioServices, who is also the operator of the facility.

[X Master]

Sphincters can say a lot if you listen closely.